Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation

This publication has 47 references indexed in Scilit:

• Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity
  Cell Death & Differentiation, 1999
• The Yin-Yang of TCF/β-Catenin Signaling
  Published by Elsevier ,1999
• Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway
  Oncogene, 1998
• Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
  Proceedings of the National Academy of Sciences, 1998
• Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
  Science, 1998
• β-catenin is a target for the ubiquitin–proteasome pathway
  The EMBO Journal, 1997
• Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells
  Current Biology, 1996
• Insulin Activates Nuclear Factor κB in Mammalian Cells through a Raf-1-mediated Pathway
  Journal of Biological Chemistry, 1995
• The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf
  Biochemical Journal, 1994
• Expression of insulin-like growth factor II, α-fetoprotein and hepatitis B virus transcripts in human primary liver cancer
  Hepatology, 1991